Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
017810.KS Stock Summary
Top 10 Correlated ETFs
017810.KS
In the News
017810.KS Financial details
Company Rating
Buy
Market Cap
414.41B
Income
15.26B
Revenue
2993.47B
Book val./share
4031.93
Cash/share
6751.18
Dividend
-
Dividend %
-
Employees
478
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-11.15
Forward P/E
-
PEG
0.87
P/S
0.13
P/B
0.96
P/C
1.74
P/FCF
12.34
Quick Ratio
-
Current Ratio
0.8
Debt / Equity
7.03
LT Debt / Equity
1.48
-
-
EPS (TTM)
286.28
EPS next Y
-
EPS next Q
-
EPS this Y
-125.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
4.68%
Revenue Q/Q
2.13%
EPS Q/Q
-98.67%
-
-
-
-
SMA20
10.79%
SMA50
10.48%
SMA100
8.49%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-9%
ROC
0.03%
Gross Margin
25%
Oper. Margin
1%
Profit Margin
-1%
Payout
-38%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9330.0-13550.0
52W High
-13.43%
52W Low
+25.72%
RSI
61
Rel Volume
1.11
Avg Volume
59.67K
Volume
66.14K
Perf Week
2%
Perf Month
9.83%
Perf Quarter
16.14%
Perf Half Y
5.3%
-
-
-
-
Beta
1
-
-
Volatility
287.59%, 534.92%
Prev Close
-1.01%
Price
11730
Change
3.71%
017810.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 63.95K | 62.04K | 68.42K | 77.19K | 81.41K | |
Net income per share | -202.34 | 317.64 | 8.26 | -1.01K | 254.69 | |
Operating cash flow per share | 2.29K | 2.79K | 3.22K | 2.58K | 5.26K | |
Free cash flow per share | -1.14K | -1.23K | -2.84K | -1.43K | 1.8K | |
Cash per share | 3.67K | 6.67K | 7.38K | 6.95K | 6.75K | |
Book value per share | 10.66K | 12.08K | 12.67K | 11.21K | 4.03K | |
Tangible book value per share | 10.98K | 12.48K | 13.23K | 12.21K | 6.59K | |
Share holders equity per share | 10.66K | 12.08K | 12.67K | 11.21K | 4.03K | |
Interest debt per share | 17.97K | 22.22K | 26.09K | 29.44K | 29.88K | |
Market cap | 418.96B | 616.57B | 636.88B | 398.96B | 391.61B | |
Enterprise value | 941.83B | 1318.21B | 1446.68B | 1309.71B | 1622.06B | |
P/E ratio | -55.6 | 52.1 | 2.09K | -10.79 | 41.82 | |
Price to sales ratio | 0.18 | 0.27 | 0.25 | 0.14 | 0.13 | |
POCF ratio | 4.91 | 5.93 | 5.38 | 4.21 | 2.02 | |
PFCF ratio | -9.83 | -13.43 | -6.08 | -7.58 | 5.92 | |
P/B Ratio | 1.06 | 1.37 | 1.36 | 0.97 | 2.64 | |
PTB ratio | 1.06 | 1.37 | 1.36 | 0.97 | 2.64 | |
EV to sales | 0.4 | 0.57 | 0.57 | 0.46 | 0.54 | |
Enterprise value over EBITDA | 6.32 | 7.46 | 7.92 | 7.33 | 7.73 | |
EV to operating cash flow | 11.03 | 12.68 | 12.21 | 13.81 | 8.38 | |
EV to free cash flow | -22.09 | -28.7 | -13.81 | -24.9 | 24.52 | |
Earnings yield | -0.02 | 0.02 | 0 | -0.09 | 0.02 | |
Free cash flow yield | -0.1 | -0.07 | -0.16 | -0.13 | 0.17 | |
Debt to equity | 1.62 | 1.78 | 2 | 2.53 | 7.03 | |
Debt to assets | 0.43 | 0.47 | 0.47 | 0.51 | 0.48 | |
Net debt to EBITDA | 3.51 | 3.97 | 4.43 | 5.1 | 5.87 | |
Current ratio | 0.75 | 0.81 | 0.88 | 0.84 | 0.75 | |
Interest coverage | 1.19 | 1.69 | 1.87 | 1.04 | 1.1 | |
Income quality | -11.33 | 8.79 | 389.55 | -2.57 | 20.67 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.05 | 0.01 | |
Payout ratio | -0.78 | 0.44 | 17.1 | -0.5 | 0.4 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.04 | 0.03 | 0.05 | 0.05 | 0.04 | |
Capex to operating cash flow | -1.5 | -1.44 | -1.88 | -1.55 | -0.66 | |
Capex to revenue | -0.05 | -0.06 | -0.09 | -0.05 | -0.04 | |
Capex to depreciation | -1.16 | -1.24 | -1.74 | -1.07 | -0.86 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.97K | 9.29K | 1.53K | 15.93K | 4.81K | |
ROIC | -0.03 | 0.02 | 0 | 0.05 | 0.04 | |
Return on tangible assets | -0.01 | 0.01 | 0 | -0.02 | 0 | |
Graham Net | -17.84K | -18.2K | -22.13K | -25.18K | -34.75K | |
Working capital | -153.35B | -146.45B | -92.85B | -140.32B | -247.66B | |
Tangible asset value | 408.9B | 464.77B | 486.99B | 448.88B | 242.18B | |
Net current asset value | -553.62B | -550.25B | -668.59B | -750.23B | 1089.46B | |
Invested capital | 1.62 | 1.78 | 2 | 2.53 | 7.03 | |
Average receivables | 213.42B | 240.17B | 276.73B | 306.19B | 298.52B | |
Average payables | 155.75B | 158.22B | 169.72B | 196.11B | 205.07B | |
Average inventory | 105.75B | 114.54B | 132.3B | 155.11B | 166.79B | |
Days sales outstanding | 34.26 | 40.56 | 42.98 | 40.61 | 34.3 | |
Days payables outstanding | 33.06 | 33.11 | 36.3 | 35.34 | 32.71 | |
Days of inventory on hand | 21.59 | 26.44 | 27.73 | 28.81 | 26.54 | |
Receivables turnover | 10.65 | 9 | 8.49 | 8.99 | 10.64 | |
Payables turnover | 11.04 | 11.02 | 10.05 | 10.33 | 11.16 | |
Inventory turnover | 16.91 | 13.81 | 13.16 | 12.67 | 13.75 | |
ROE | -0.02 | 0.03 | 0 | -0.09 | 0.06 | |
Capex per share | -3.44K | -4.02K | -6.06K | -4.01K | -3.47K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.78K | 19.85K | 20.54K | 20.29K | 20.72K | |
Net income per share | -1.35K | 47.82 | 130.75 | 234.02 | 2.38 | |
Operating cash flow per share | 476.89 | 532.37 | 2.06K | 1.81K | 865.83 | |
Free cash flow per share | -277.78 | -396.1 | 1.17K | 1K | 21.06 | |
Cash per share | 6.95K | 5.16K | 5.53K | 7.75K | 6.75K | |
Book value per share | 11.21K | 9K | 8.97K | 10.96K | 4.03K | |
Tangible book value per share | 12.21K | 8.92K | 9.94K | 11.96K | 6.59K | |
Share holders equity per share | 11.21K | 9K | 8.97K | 10.96K | 4.03K | |
Interest debt per share | 28.7K | 30.12K | 29.91K | 30.05K | 28.73K | |
Market cap | 398.96B | 368.81B | 383.15B | 404.85B | 391.61B | |
Enterprise value | 1309.71B | 1319.22B | 1351.44B | 1359.82B | 1622.06B | |
P/E ratio | -2.01 | 52.43 | 19.92 | 11.76 | 1.12K | |
Price to sales ratio | 0.55 | 0.51 | 0.51 | 0.54 | 0.51 | |
POCF ratio | 22.75 | 18.84 | 5.06 | 6.09 | 12.3 | |
PFCF ratio | -39.06 | -25.32 | 8.89 | 10.99 | 505.65 | |
P/B Ratio | 0.97 | 1.11 | 1.16 | 1 | 2.64 | |
PTB ratio | 0.97 | 1.11 | 1.16 | 1 | 2.64 | |
EV to sales | 1.8 | 1.81 | 1.79 | 1.82 | 2.13 | |
Enterprise value over EBITDA | 54.73 | 7.25 | 6.86 | 6.92 | 32.96 | |
EV to operating cash flow | 74.69 | 67.39 | 17.86 | 20.45 | 50.95 | |
EV to free cash flow | -128.23 | -90.58 | 31.34 | 36.92 | 2.09K | |
Earnings yield | -0.12 | 0 | 0.01 | 0.02 | 0 | |
Free cash flow yield | -0.03 | -0.04 | 0.11 | 0.09 | 0 | |
Debt to equity | 2.53 | 3.32 | 3.29 | 2.7 | 7.03 | |
Debt to assets | 0.51 | 0.55 | 0.54 | 0.52 | 0.48 | |
Net debt to EBITDA | 38.06 | 5.22 | 4.91 | 4.86 | 25 | |
Current ratio | 0.84 | 0.72 | 0.72 | 0.8 | 0.75 | |
Interest coverage | -1.07 | 1.44 | 1.19 | 1.49 | 0.8 | |
Income quality | -0.35 | 11.13 | 21.44 | 9.26 | 364.03 | |
Dividend Yield | 0.03 | 0 | 0.01 | 0.15 | 0.03 | |
Payout ratio | -0.27 | 0 | 0.78 | 7.08 | 146.73 | |
Sales general and administrative to revenue | 0.01 | 0.23 | 0.24 | 0.23 | 0.01 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Capex to operating cash flow | -1.58 | -1.74 | -0.43 | -0.45 | -0.98 | |
Capex to revenue | -0.04 | -0.05 | -0.04 | -0.04 | -0.04 | |
Capex to depreciation | -0.75 | -0.97 | -0.91 | -0.77 | -0.81 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.46K | 3.11K | 5.14K | 7.6K | 464.51 | |
ROIC | -0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Return on tangible assets | -0.03 | 0 | 0 | 0 | 0 | |
Graham Net | -25.18K | -27.89K | -28.02K | -26.34K | -34.75K | |
Working capital | -140.32B | -260.33B | -263B | -196.2B | -247.66B | |
Tangible asset value | 448.88B | 368.51B | 365.61B | 439.79B | 242.18B | |
Net current asset value | -750.23B | -855.43B | -863.89B | -803.77B | 1089.46B | |
Invested capital | 2.53 | 3.32 | 3.29 | 2.7 | 7.03 | |
Average receivables | 327.34B | 309.05B | 299.54B | 309.96B | 302.23B | |
Average payables | 202.87B | 197.86B | 194.35B | 201.83B | 203.44B | |
Average inventory | 165.35B | 164.92B | 161.22B | 156.18B | 157.95B | |
Days sales outstanding | 39.07 | 37.27 | 35.35 | 38.99 | 33.22 | |
Days payables outstanding | 32.89 | 30.99 | 32.23 | 33.36 | 31.16 | |
Days of inventory on hand | 26.81 | 26.46 | 26 | 24.73 | 25.28 | |
Receivables turnover | 2.3 | 2.41 | 2.55 | 2.31 | 2.71 | |
Payables turnover | 2.74 | 2.9 | 2.79 | 2.7 | 2.89 | |
Inventory turnover | 3.36 | 3.4 | 3.46 | 3.64 | 3.56 | |
ROE | -0.12 | 0.01 | 0.01 | 0.02 | 0 | |
Capex per share | -754.67 | -928.46 | -884.93 | -807.17 | -844.77 |
017810.KS Frequently Asked Questions
What is Pulmuone Co., Ltd. stock symbol ?
Pulmuone Co., Ltd. is a KR stock and trading under the symbol 017810.KS
What is Pulmuone Co., Ltd. stock quote today ?
Pulmuone Co., Ltd. stock price is $11730 today.
Is Pulmuone Co., Ltd. stock public?
Yes, Pulmuone Co., Ltd. is a publicly traded company.